New drug combo shows promise for stubborn low-platelet disorder
NCT ID NCT05438875
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 26 times
Summary
This study tested whether adding ATRA to the standard drug eltrombopag works better than eltrombopag alone for adults with immune thrombocytopenia (ITP) that did not respond to steroids. ITP causes low platelet counts, leading to bleeding risks. The trial enrolled 96 participants and measured how many achieved a stable platelet count without bleeding for 18 months. The goal is to find a more effective treatment option for this challenging condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PURPURA, THROMBOCYTOPENIC, IDIOPATHIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Tongren hospital
Beijing, Beijing Municipality, China
-
Department of Hematology, Beijing Friendship Hospital, Capital Medical University
Beijing, China
-
Department of Hematology, Beijing Hospital
Beijing, China
-
Department of Hematology, Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital
Beijing, China
-
Peking University Insititute of Hematology, Peking University People's Hospital
Beijing, Beijing Municipality, 100010, China
Conditions
Explore the condition pages connected to this study.